Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BioretecOHEL:BRETEC -4.42% Gross Margin % is 69.48% as of Dec. 2025, which is 1% below its 10-year median of 70.36. The stock has 5 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Bioretec ranks better than 58.56% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Bioretec's Gross Profit for the
six
months ended in Dec. 2025 was €1.01 Mil. Bioretec's Revenue for the
six
months ended in Dec. 2025 was €1.45 Mil. Therefore, Bioretec's Gross Margin % for the quarter that ended in Dec. 2025 was 69.48%.
Warning Sign:
Bioretec Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.4%.
The historical rank and industry rank for Bioretec's Gross Margin % or its related term are showing as below:
OHEL:BRETEC'
s Gross Margin % Range Over the Past 10 Years
Min: 57.61 Med: 70.36 Max: 73.45
Current: 57.61
During the past 8 years, the highestGross Margin % of Bioretec was 73.45%. The lowest was 57.61%. And the median was 70.36%.
OHEL:BRETEC's Gross Margin % is ranked better than 58.56% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 52.115
vs OHEL:BRETEC: 57.61
Bioretec had a gross margin of 69.48% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Bioretec was -1.40% per year.
Bioretec (OHEL:BRETEC) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Bioretec had a gross margin of 69.48% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Bioretec Gross Margin % Related Terms
Bioretec Gross Margin % Historical Data
* Premium members only.
The historical data trend for Bioretec's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OHEL:BRETEC vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Bioretec's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioretec Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bioretec's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Bioretec's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Bioretec (OHEL:BRETEC) has a Gross Margin % of 69.48% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Bioretec and its competitors. This is near median its historical median of 70.36. Over the past decade, Bioretec's Gross Margin % has ranged from 57.61 to 73.45. According to the industry distribution chart, Bioretec ranks #334 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 41.4%.
Is Bioretec's Gross Margin % too high?
Bioretec's current Gross Margin % of 69.48% is near median its 10-year median of 70.36. Over the past 10 years, this metric has ranged from a low of 57.61 to a high of 73.45. The Medical Devices & Instruments industry median Gross Margin % is 52.12. Bioretec's value of 69.48% is 33.3% above this industry median. Based on the distribution chart, Bioretec ranks #334 out of 806 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Bioretec's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bioretec ranks #334 out of 806 companies for Gross Margin %. This puts Bioretec in the upper half of its industry. The industry median Gross Margin % is 52.12. Bioretec's value of 69.48% is 33.3% above this benchmark. Historically, Bioretec's own Gross Margin % has ranged from 57.61 to 73.45 over the past decade. While the company's 10-year median is 70.36 vs. the industry median of 52.12, Bioretec has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.12, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioretec's current Gross Margin % of 69.48% is 33.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Bioretec and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioretec's current Gross Margin % is 69.48%, which is near median its own 10-year median of 70.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioretec stock overvalued right now?
Based on GuruFocus' analysis, Bioretec (OHEL:BRETEC) is currently considered Possible Value Trap. The stock's GF Value™ is €0.19, compared to a current price of €0.02 — trading 88.6% below its estimated fair value. The current Gross Margin % is 69.48%, which is near median its 10-year median of 70.36 and 33.3% above the Medical Devices & Instruments industry median of 52.12. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Bioretec (OHEL:BRETEC), the current Gross Margin % is 69.48% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bioretec Ltd is a medical device company focusing on the development of bioabsorbable and bioresorbable implants for pediatric and adult orthopedics. It has developed the following product lines: RemeOs and Activa. RemeOs is based on a high-performance magnesium alloy and hybrid composite, introducing absorbable materials for enhanced surgical outcomes. The RemeOs implants (RemeOs Screw Lag, RemeOs Screw Lag Solid, RemeOs Screw FT, etc.) are absorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The Activa implants (ActivaPin, ActivaNail, ActivaScrew, etc.) are based on fully absorbable biopolymer products that facilitate natural bone healing without requiring removal surgery.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OHEL:BRETEC has been successfully added to your 
